BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 23913621)

  • 1. CTNNB1 45F mutation is a molecular prognosticator of increased postoperative primary desmoid tumor recurrence: an independent, multicenter validation study.
    Colombo C; Miceli R; Lazar AJ; Perrone F; Pollock RE; Le Cesne A; Hartgrink HH; Cleton-Jansen AM; Domont J; Bovée JV; Bonvalot S; Lev D; Gronchi A
    Cancer; 2013 Oct; 119(20):3696-702. PubMed ID: 23913621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of CTNNB1 gene mutation in primary sporadic aggressive fibromatosis.
    van Broekhoven DL; Verhoef C; Grünhagen DJ; van Gorp JM; den Bakker MA; Hinrichs JW; de Voijs CM; van Dalen T
    Ann Surg Oncol; 2015 May; 22(5):1464-70. PubMed ID: 25341748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific mutations in the beta-catenin gene (CTNNB1) correlate with local recurrence in sporadic desmoid tumors.
    Lazar AJ; Tuvin D; Hajibashi S; Habeeb S; Bolshakov S; Mayordomo-Aranda E; Warneke CL; Lopez-Terrada D; Pollock RE; Lev D
    Am J Pathol; 2008 Nov; 173(5):1518-27. PubMed ID: 18832571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. β-Catenin mutation status and outcomes in sporadic desmoid tumors.
    Mullen JT; DeLaney TF; Rosenberg AE; Le L; Iafrate AJ; Kobayashi W; Szymonifka J; Yeap BY; Chen YL; Harmon DC; Choy E; Yoon SS; Raskin KA; Hornicek FJ; Nielsen GP
    Oncologist; 2013; 18(9):1043-9. PubMed ID: 23960186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of
    Guo L; Wang X; Xu B; Lang R; Hu B
    Future Oncol; 2021 Feb; 17(4):435-442. PubMed ID: 33397129
    [No Abstract]   [Full Text] [Related]  

  • 6. Risk factors of local recurrence after surgery in extraabdominal desmoid-type fibromatosis: A multicenter study in Japan.
    Nishida Y; Hamada S; Kawai A; Kunisada T; Ogose A; Matsumoto Y; Ae K; Toguchida J; Ozaki T; Hirakawa A; Motoi T; Sakai T; Kobayashi E; Gokita T; Okamoto T; Matsunobu T; Shimizu K; Koike H
    Cancer Sci; 2020 Aug; 111(8):2935-2942. PubMed ID: 32539220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Desmoid tumor: analysis of prognostic factors and outcomes in a surgical series.
    Mullen JT; Delaney TF; Kobayashi WK; Szymonifka J; Yeap BY; Chen YL; Rosenberg AE; Harmon DC; Choy E; Yoon SS; Raskin KA; Petur Nielsen G; Hornicek FJ
    Ann Surg Oncol; 2012 Dec; 19(13):4028-35. PubMed ID: 22965569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local recurrence after surgery for primary extra-abdominal desmoid-type fibromatosis.
    van Broekhoven DL; Verhoef C; Elias SG; Witkamp AJ; van Gorp JM; van Geel BA; Wijrdeman HK; van Dalen T
    Br J Surg; 2013 Aug; 100(9):1214-9. PubMed ID: 23804156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Prognostic Role of β-Catenin Mutations in Desmoid-type Fibromatosis Undergoing Resection Only: A Meta-analysis of Individual Patient Data.
    Timbergen MJM; Colombo C; Renckens M; Kim HS; Rosmalen JV; Salas S; Mullen JT; Colombo P; Nishida Y; Wiemer EAC; Verhoef C; Sleijfer S; Gronchi A; Grünhagen DJ
    Ann Surg; 2021 Jun; 273(6):1094-1101. PubMed ID: 31804402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors for extra-abdominal and abdominal wall desmoids: a 20-year experience at a single institution.
    Huang K; Fu H; Shi YQ; Zhou Y; Du CY
    J Surg Oncol; 2009 Dec; 100(7):563-9. PubMed ID: 19722232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical treatment of pediatric desmoid tumors. A 12-year, single-center experience.
    Soto-Miranda MA; Sandoval JA; Rao B; Neel M; Krasin M; Spunt S; Jenkins JJ; Davidoff AM; Ver Halen JP
    Ann Surg Oncol; 2013 Oct; 20(11):3384-90. PubMed ID: 23838914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does the Addition of Mutations of CTNNB1 S45F to Clinical Factors Allow Prediction of Local Recurrence in Patients With a Desmoid Tumor? A Local Recurrence Risk Model.
    Pinto FFE; Mello CAL; Nakagawa SA; Chung WT; Torrezan GT; Barros BDF; Cunha IW; Calsavara VF; Carraro DM; Lopes A
    Clin Orthop Relat Res; 2023 Oct; 481(10):1978-1989. PubMed ID: 37104792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation-induced Sarcomas Occurring in Desmoid-type Fibromatosis Are Not Always Derived From the Primary Tumor.
    Verschoor AJ; Cleton-Jansen AM; Wijers-Koster P; Coffin CM; Lazar AJ; Nout RA; Rubin BP; Gelderblom H; Bovée JV
    Am J Surg Pathol; 2015 Dec; 39(12):1701-7. PubMed ID: 26414222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors for the recurrence of sporadic desmoid-type fibromatosis after macroscopically complete resection: Analysis of 114 patients at a single institution.
    He XD; Zhang YB; Wang L; Tian ML; Liu W; Qu Q; Li BL; Hong T; Li NC; Na YQ
    Eur J Surg Oncol; 2015 Aug; 41(8):1013-9. PubMed ID: 26005133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chest-wall desmoid tumors: results of surgical intervention.
    Abbas AE; Deschamps C; Cassivi SD; Nichols FC; Allen MS; Schleck CD; Pairolero PC
    Ann Thorac Surg; 2004 Oct; 78(4):1219-23; discussion 1219-23. PubMed ID: 15464474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 'Difficult to diagnose' desmoid tumours: a potential role for CTNNB1 mutational analysis.
    Colombo C; Bolshakov S; Hajibashi S; Lopez-Terrada L; Wang WL; Rao P; Benjamin RS; Lazar AJ; Lev D
    Histopathology; 2011 Aug; 59(2):336-40. PubMed ID: 21884214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CTNNB1 genotyping and APC screening in pediatric desmoid tumors: a proposed algorithm.
    Wang WL; Nero C; Pappo A; Lev D; Lazar AJ; López-Terrada D
    Pediatr Dev Pathol; 2012; 15(5):361-7. PubMed ID: 22372443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wnt targets genes are not differentially expressed in desmoid tumors bearing different activating β-catenin mutations.
    Timbergen MJM; Janssen ML; Verhoef C; Grünhagen DJ; Chibon F; Smid M; Sleijfer S; Wiemer EAC
    Eur J Surg Oncol; 2019 Apr; 45(4):691-698. PubMed ID: 30528042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resection of adrenocortical carcinoma liver metastasis: is it justified?
    Gaujoux S; Al-Ahmadie H; Allen PJ; Gonen M; Shia J; D'Angelica M; Dematteo R; Fong Y; Blumgart L; Jarnagin WR
    Ann Surg Oncol; 2012 Aug; 19(8):2643-51. PubMed ID: 22526905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of aggressive fibromatosis: a retrospective study of 72 patients followed for 1-27 years.
    Sørensen A; Keller J; Nielsen OS; Jensen OM
    Acta Orthop Scand; 2002 Apr; 73(2):213-9. PubMed ID: 12079022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.